Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology Annual meeting, part 2 …
We live in the “era” of minimally invasive procedures, molecular testing, and personalized
care. Effusions have a high sensitivity and will often yield diagnostic cytological material …
care. Effusions have a high sensitivity and will often yield diagnostic cytological material …
Advanced non-small cell lung cancer with activating epidermal growth factor receptor mutation: first line treatment and beyond
D Rocco, C Battiloro, LD Gravara… - Reviews on Recent …, 2019 - ingentaconnect.com
Background: Lung cancer is the leading cause of cancer mortality, being responsible for
more than 1.6 million deaths each year worldwide and non-small-cell lung cancer (NSCLC) …
more than 1.6 million deaths each year worldwide and non-small-cell lung cancer (NSCLC) …
Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma
Objectives Adenocarcinoma (ADC) to squamous cell carcinoma (SCC) transformation (AST)
is reported in epidermal growth factor receptor (EGFR)-mutated non–small cell lung cancer …
is reported in epidermal growth factor receptor (EGFR)-mutated non–small cell lung cancer …
Biomarkers in non-small cell lung cancers: Indian consensus guidelines for molecular testing
K Prabhash, SH Advani, U Batra, B Biswas… - Advances in …, 2019 - Springer
Novel molecular targets and promising targeted therapies have reshaped diagnostics in
patients with advanced non-small cell lung cancer (NSCLC). Despite this progress, the …
patients with advanced non-small cell lung cancer (NSCLC). Despite this progress, the …
Clinicopathological Characteristics And EGFR-TKIs Efficacies In Lung Squamous Cell Carcinoma Patients Harboring An EGFR Sensitizing Mutation
S Zhou, H Wang, W Jiang, Q Yu - OncoTargets and therapy, 2019 - Taylor & Francis
Objective This study analyzed the relationship between the clinicopathological features and
epidermal growth factor receptor (EGFR) mutation status of squamous cell lung cancer …
epidermal growth factor receptor (EGFR) mutation status of squamous cell lung cancer …
[HTML][HTML] Identification of high expression profiles of miR-31-5p and its vital role in lung squamous cell carcinoma: a survey based on qRT-PCR and bioinformatics …
XJ Chi, LL Wei, Q Bu, N Mo, XY Chen… - Translational Cancer …, 2019 - ncbi.nlm.nih.gov
Background The function of miR-31-5p in lung squamous cell carcinoma (LUSC) remains
unclear, therefore, a systematic study was performed for the clinical significance and …
unclear, therefore, a systematic study was performed for the clinical significance and …
[PDF][PDF] 1 例晚期肺鳞癌患者EGFR 突变病例报道并文献复习
周海英， 韩进伟， 吕铮， 吴爱萍 - 临床与病理杂志, 2019 - cdn.amegroups.cn
1 例表皮生长因子受体(epidermal growth factor receptor, EGFR) 突变阳性的晚期肺鳞癌患者,
男, 65 岁, 无明显诱因出现刺激性咳嗽10 余天. 胸部CT 见右下肺实性肿块, 隆突下肿大淋巴结 …
男, 65 岁, 无明显诱因出现刺激性咳嗽10 余天. 胸部CT 见右下肺实性肿块, 隆突下肿大淋巴结 …
[PDF][PDF] Histologic grade with thyroid transcription factor 1 and sample type serve as independent factors for the incidence of EGFR mutations in Nonsmall cell lung …
HT Nguyen, T Van Hoang, DB Nguyen, TQ Pham… - EJMO, 2019 - ejmo.org
Objectives: This study aims to describe the characteristics of epidermal growth factor
receptor (EGFR) mutations in correlation with clinical features of Vietnamese non-small cell …
receptor (EGFR) mutations in correlation with clinical features of Vietnamese non-small cell …
Detection of clinically relevant epidermal growth factor receptor pathway mutations in circulating cell-free tumor DNA using next generation sequencing in squamous …
KB Govind, D Koppaka, L Dasappa… - South Asian Journal …, 2019 - thieme-connect.com
Background: Limited repertoires of targets are available in the management of squamous
cell carcinoma lung. In this study, we analyzed epidermal growth factor receptor (EGFR) …
cell carcinoma lung. In this study, we analyzed epidermal growth factor receptor (EGFR) …